Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers

Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers

US Patent 9132120 · Granted Sep 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2019
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs i2018
Compounds that inhibit human DNA ligases and methods of treating cancer2017
Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers2017
Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers2017
Compounds that inhibit human DNA ligases and methods of treating cancer2015
Compounds that inhibit human DNA ligases and methods of treating cancer2013